QIAGEN Launches CE-marked Version of QuantiFERON® SARS-CoV-2 to Assess T-cell Response to COVID-19

Gerelateerde artikelen

Bekijk profiel

QIAGEN continues to update its range of automation solutions with the launch of high-sensitive capillary electrophoresis instrument QIAxcel Connect

QIAGEN launches QIAwave portfolio of environmentally friendly products

18 januari 2022